U

UT Southwestern Medical Center

Academic medical center and health system

Research Scientist - Cancer Biology and Osteosarcoma, Levi Lab

Full-Time
No salary listed
Expert
Bachelor's, Master's, PhD
Dallas, TX, USA
In Person
Academic & Institutional ResearchLife Sciences Research

About the job

Requirements
  • A PhD, Master's degree, or Bachelor's degree with major coursework in the field of assignment is required.
  • With a PhD, five years of research experience in the field of assignment are required, including two years at the level of Senior Research Associate or equivalent.
  • With a Master's degree, seven years of research experience in the field of assignment are required, including three years at the level of Senior Research Associate or equivalent.
  • With a Bachelor's degree, nine years of research experience in the field of assignment are required, including four years at the level of Senior Research Associate or equivalent.
Responsibilities
  • Design and execute hypothesis-driven studies addressing osteosarcoma initiation, growth, heterogeneity, invasion, metastasis, cancer-associated pain, and treatment response.
  • Investigate tumor-intrinsic signaling and tumor microenvironment interactions, including neural, neuropeptide, adrenergic, immune, stromal, and vascular mechanisms.
  • Develop and maintain osteosarcoma cell culture systems, including established or patient-derived models when available, drug-response assays, proliferation and viability assays, migration or invasion assays, and three-dimensional spheroid or extracellular matrix models.
  • Conduct in vivo cancer studies using orthotopic and other appropriate osteosarcoma models, including animal handling, tumor implantation, injections or drug administration, longitudinal monitoring, bioluminescence imaging, tissue collection, and assessment of primary tumors and pulmonary metastases.
  • Perform molecular and cellular assays such as DNA and RNA extraction, PCR and quantitative PCR, western blotting, ELISA, cloning, gene perturbation or CRISPR-Cas9 approaches, and next-generation sequencing workflows.
  • Perform tissue processing and quantitative pathology, including fixation, decalcification, embedding, sectioning, H&E staining, immunohistochemistry, immunofluorescence, slide scanning, confocal microscopy, and image analysis.
  • Use flow cytometry and cell sorting to identify and isolate malignant, immune, stromal, and vascular populations from tumors and metastatic tissues.
  • Support single-cell and bulk RNA sequencing studies from experimental design and tissue dissociation through quality control, cell annotation, pathway analysis, cell-state analysis, and biological validation in collaboration with computational colleagues.
  • Evaluate candidate therapeutics and pathway inhibitors in vitro and in vivo using appropriate controls, dose and time-course studies, blinded outcome assessment, and reproducible statistical analysis.
  • Maintain accurate experimental records; manage cell lines, mouse colonies, human tissue samples, reagents, and datasets; and ensure compliance with institutional biosafety, animal-use, and human-subjects requirements.
  • Develop, optimize, document, and train others in standard operating procedures that improve rigor, reproducibility, efficiency, and data quality.
  • Analyze and interpret data using relevant statistical, imaging, and bioinformatics tools; troubleshoot unexpected results; and revise experimental approaches based on evidence.
  • Prepare figures, manuscripts, abstracts, presentations, progress reports, and grant materials, and present work at laboratory meetings and scientific conferences.
  • Plan, organize, coordinate, direct, and personally participate in assigned scientific or medical research projects; select or assist in selecting key research personnel; determine specific goals or objectives; assign and review work of subordinates; and plan experimental protocols.
  • Review and analyze resulting research data, revising techniques or approaches to work problems as indicated by the data.
  • Compile, write, and submit research results to a supervisor; prepare or assist in preparing research papers, reports, and abstracts for publication as a co-author.
  • Design, develop, or adapt equipment used in experiments or research to obtain desired results.
  • Plan and supervise training of technicians and other laboratory personnel in proper laboratory techniques, use of laboratory equipment, and safety procedures.
  • Supervise a group of employees of lower grade engaged in technical and professional work ranging from routine to complex laboratory tasks.
  • Confer with industrial, governmental, or other groups concerning progress or results of research projects as needed.
  • Perform other duties as assigned.
Desired Qualifications
  • Research experience in cancer biology, sarcoma biology, bone biology, tumor microenvironment biology, cancer neuroscience, metastasis, or a closely related field.
  • Hands-on experience with mammalian cell culture and functional cancer assays, ideally including osteosarcoma models, pharmacologic perturbation, and three-dimensional spheroid, organoid, or extracellular matrix systems.
  • Experience with mouse cancer models, preferably orthotopic xenograft or syngeneic models, longitudinal tumor measurements, bioluminescence imaging, drug administration, survival studies, and metastatic burden assessment.
  • Proficiency in molecular biology methods such as PCR, quantitative PCR, western blotting, nucleic acid isolation, cloning, gene knockdown or knockout, CRISPR-Cas9 editing, and library preparation for next-generation sequencing.
  • Experience with histology and quantitative imaging, including bone or mineralized tissue processing, decalcification, immunohistochemistry, immunofluorescence, confocal or whole-slide imaging, and image-based quantification.
  • Experience with multicolor flow cytometry, fluorescence-activated cell sorting, and analysis of heterogeneous tumors or metastatic tissues.
  • Experience generating or analyzing single-cell RNA sequencing, bulk RNA sequencing, spatial transcriptomic, or other multiomic data. Familiarity with R, Python, Seurat, Scanpy, or related tools is advantageous.
  • Understanding of cancer cell signaling, cell-cycle control, apoptosis, angiogenesis, immune and stromal biology, extracellular matrix remodeling, and mechanisms of invasion, metastasis, and treatment resistance.
  • Experience with rigorous experimental design, power and sample-size considerations, randomization, blinding, data visualization, statistical analysis, and transparent reporting.
  • Ability to mentor and supervise junior research personnel while fostering a respectful, inclusive, collaborative, and accountable laboratory culture.
  • Ability to plan and advance multiple projects with increasing scientific independence.
  • Critical thinking, troubleshooting, organizational, and project-management skills.
  • Scientific writing, oral communication, figure preparation, and data-presentation skills.
  • Ability to collaborate across disciplines and communicate effectively with basic scientists, clinicians, computational researchers, trainees, and external partners.
  • Commitment to research integrity, reproducibility, responsible data stewardship, laboratory safety, and respectful mentorship.

About the company

U

UT Southwestern Medical Center

View

UT Southwestern Medical Center is an academic medical center in Dallas, Texas, integrating patient care, biomedical research, and medical education. It operates a main campus and regional medical centers alongside four schools, including a medical school and graduate programs in health professions and public health. What sets UT Southwestern apart is research output ranked No. 1 worldwide by the Nature Index, backed by Nobel laureates on faculty. The goal is to advance medical discovery into better treatments and compassionate patient care.

Company Size

N/A

Company Stage

Grant

Total Funding

$18M

Headquarters

Dallas, Texas

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • The Stephens Greth Foundation gave $100 million on April 1, 2026 for the pediatric campus.
  • InterAct licensing on March 24, 2026 targets metastatic cancer commercialization and royalties.
  • World Cup 26 and Dallas Pulse partnerships expand brand visibility and community recruiting in 2026.

What critics are saying

  • Paxton sued affiliate Jason Jarin on February 18, 2026, escalating Texas care restrictions.
  • UT Southwestern lists twelve physician departures closing practices by June 30, 2026.
  • Research reliance on NIH, ARPA-H, and state grants exposes labs to political budget shocks.

What makes UT Southwestern Medical Center unique

  • UT Southwestern won up to $25 million ARPA-H funding for VITAL on January 12, 2026.
  • Simmons Cancer Center joined AccessHope’s network in June 2024, extending national oncology reach.
  • UT Southwestern operates the Texas Behavioral Health Center, opened June 16, 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Paid Vacation
  • Paid Parental Leave
  • 401(k) Retirement Plan
  • Wellness Program
  • Tuition Reimbursement
  • Public Service Loan Forgiveness (PSLF) Qualified Employer

Company News

Intelligence360 News
Jun 13th, 2025
Ut Southwestern Medical Center To Spend $1,500,000.00 To Occupy 1,500 Square Feet Of Space In Dallas Texas.

Dallas, Texas — According to state and local development sources, UT Southwestern Medical Center plans to invest $1,500,000.00 to build out 1,500 square feet of new space in Dallas. The company plans to occupy the new space at 2201 Inwood Road in Dallas, on or about March 1, 2026. According to the company website UT Southwestern is an academic medical center, world-renowned for its research, regarded among the best in the country for medical education and for clinical and scientific training, and nationally recognized for the quality of care its faculty provides to patients at UT Southwesterns University Hospital & Clinics and affiliated institutions. The Medical Center includes three degree-granting institutions: UT Southwestern Medical School, UT Southwestern Graduate School of Biomedical Sciences, and UT Southwestern School of Health Professions. The schools train nearly 3,700 medical, graduate, and health profession students, residents, and postdoctoral fellows each year. Ongoing support from federal agencies, along with foundations, individuals, and corporations, provides more than $524 million per year to fund faculty research

PR Newswire
Oct 15th, 2024
Accesshope And Webtpa Join Forces To Bring Virtual Cancer Care Support To More Employers

Collaboration expands WebTPA's cancer care solution to give employers and their employees access to expertise from top cancer specialists across the U.S. DUARTE, Calif. and SAN FRANCISCO, Oct. 15, 2024 /PRNewswire/ -- AccessHope, LLC, a cancer support services company, and WebTPA Employer Services, LLC, a healthcare benefits administrator with 30+ years of experience managing custom health plans and serving over 3.1 million members, today announced they have launched a collaboration to extend AccessHope's services to WebTPA's self-insured employers and their plan members. Eligible members will now have access to remote expertise from National Cancer Institute (NCI)-Designated Comprehensive Cancer Center subspecialists knowledgeable in the latest cancer discoveries and clinical trials. These specialists will be available to review cancer diagnoses, treatment plans and personalized precision medicine opportunities, providing expertise that can support treating oncologists and their patients at any point in their cancer journey

Yahoo Finance
Jun 12th, 2024
Accesshope Announces Collaboration With Ut Southwestern Medical Center To Expand Cancer Expertise Access In Southern States

UT Southwestern Harold C. Simmons Comprehensive Cancer Center is the seventh National Cancer Institute-Designated Comprehensive Cancer Center to join AccessHope's networkNationally recognized oncologists from UT Southwestern Harold C. Simmons Comprehensive Cancer Center will review cases for AccessHope's employer plan members to help their treating oncologists optimize cancer treatment plansDUARTE, Calif., June 12, 2024 /PRNewswire/ -- AccessHope, LLC , a company changing the way leading-edge cancer expertise is delivered, today announced that UT Southwestern Harold C. Simmons Comprehensive Cancer Center will become the seventh National Cancer Institute (NCI)-designated center in the AccessHope network. Through this collaboration, more people living with complex cancer will have access to insights on targeted treatments and potential clinical trials from oncology experts at Simmons Cancer Center based in Dallas.AccessHope Logo (PRNewsfoto/AccessHope)"Since its inception, AccessHope's mission has been to deploy the latest cancer care knowledge to the places and people who need it most, when it is most valuable — ensuring that every member, no matter where they live, has access to the best treatment knowledge to meet their unique needs," said AccessHope CEO Brad Kreick. "The addition of Simmons Cancer Center to our growing roster of foundational partners further extends our ability to help more people with cancer

Intelligence360 News
May 27th, 2024
Ut Southwestern Medical Center To Spend $4,284,815.00 To Occupy 25,987 Square Feet Of Space In Dallas Texas.

Dallas, Texas — According to state and local development sources, UT Southwestern Medical Center plans to invest $4,284,815.00 to build out 25,987 square feet of new space in Dallas. The company plans to occupy the new space at 8611 Hillcrest Road, Suite 350 and 250 in Dallas, on or about January 1, 2025. According to the company website UT Southwestern is an academic medical center, world-renowned for its research, regarded among the best in the country for medical education and for clinical and scientific training, and nationally recognized for the quality of care its faculty provides to patients at UT Southwesterns University Hospital & Clinics and affiliated institutions. The Medical Center includes three degree-granting institutions: UT Southwestern Medical School, UT Southwestern Graduate School of Biomedical Sciences, and UT Southwestern School of Health Professions. The schools train nearly 3,700 medical, graduate, and health profession students, residents, and postdoctoral fellows each year. Ongoing support from federal agencies, along with foundations, individuals, and corporations, provides more than $524 million per year to fund faculty research

Dallas Next
Mar 28th, 2023
UT Southwestern Researchers Secure $18 Million in Funding to Improve Postpartum Health Outcomes

UT Southwestern says the funding award is a significant step towards improving postpartum health outcomes for low-income women of color. The study aims to determine the best way to use technology to improve access to maternal health care and decrease complications after birth.